Literature DB >> 25037038

A study of cardiovascular miRNA biomarkers for Kawasaki disease.

Anne H Rowley1, Adam J Pink, Rebecca Reindel, Nancy Innocentini, Susan C Baker, Stanford T Shulman, Kwang-Youn A Kim.   

Abstract

We hypothesized that cardiovascular miRNAs might be diagnostic biomarkers for Kawasaki disease (KD). We identified dysregulated miRNAs in KD coronary arteries, and tested sera from KD patients and febrile controls for cardiovascular miRNAs using 2 methods. We did not identify cardiovascular miRNAs diagnostic for KD; our results may help guide future studies of potential miRNA biomarkers for KD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25037038      PMCID: PMC4229439          DOI: 10.1097/INF.0000000000000449

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  9 in total

1.  Analyzing real-time PCR data by the comparative C(T) method.

Authors:  Thomas D Schmittgen; Kenneth J Livak
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

2.  Analysis of circulating microRNA: preanalytical and analytical challenges.

Authors:  Jennifer S McDonald; Dragana Milosevic; Honey V Reddi; Stefan K Grebe; Alicia Algeciras-Schimnich
Journal:  Clin Chem       Date:  2011-04-12       Impact factor: 8.327

3.  A high-density quantitative nuclease protection microarray platform for high throughput analysis of gene expression.

Authors:  K M Bourzac; M P Rounseville; X Zarate; V S R K Maddula; D C Henderson; J A Luckey; B Seligmann; D W Galbraith
Journal:  J Biotechnol       Date:  2011-04-08       Impact factor: 3.307

4.  Elevated serum level of microRNA (miRNA)-200c and miRNA-371-5p in children with Kawasaki disease.

Authors:  Ki Wook Yun; Ji Young Lee; Sin Weon Yun; In Seok Lim; Eung Sang Choi
Journal:  Pediatr Cardiol       Date:  2013-11-21       Impact factor: 1.655

5.  Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies.

Authors:  Colin C Pritchard; Evan Kroh; Brent Wood; Jason D Arroyo; Katy J Dougherty; Melanie M Miyaji; Jonathan F Tait; Muneesh Tewari
Journal:  Cancer Prev Res (Phila)       Date:  2011-12-12

6.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Circulation       Date:  2004-10-26       Impact factor: 29.690

Review 7.  Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases.

Authors:  Anke J Tijsen; Yigal M Pinto; Esther E Creemers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-31       Impact factor: 4.733

8.  Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study.

Authors:  Jan Marc Orenstein; Stanford T Shulman; Linda M Fox; Susan C Baker; Masato Takahashi; Tricia R Bhatti; Pierre A Russo; Gary W Mierau; Jean Pierre de Chadarévian; Elizabeth J Perlman; Cynthia Trevenen; Alexandre T Rotta; Mitra B Kalelkar; Anne H Rowley
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

9.  Differential expression of miR-145 in children with Kawasaki disease.

Authors:  Chisato Shimizu; Jihoon Kim; Petra Stepanowsky; Christine Trinh; Hubert D Lau; Johnny C Akers; Clark Chen; John T Kanegaye; Adriana Tremoulet; Lucila Ohno-Machado; Jane C Burns
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

  9 in total
  16 in total

1.  Serum miR-92a-3p as a New Potential Biomarker for Diagnosis of Kawasaki Disease with Coronary Artery Lesions.

Authors:  Xing Rong; Lianhong Jia; Lanlan Hong; Lulu Pan; Xiangyang Xue; Chunxiang Zhang; Jiacheng Lu; Zengyou Jin; Huixian Qiu; Rongzhou Wu; Maoping Chu
Journal:  J Cardiovasc Transl Res       Date:  2016-12-15       Impact factor: 4.132

2.  Analysis of Circular RNAs in the Coronary Arteries of Patients with Kawasaki Disease.

Authors:  Young-Kook Kim
Journal:  J Lipid Atheroscler       Date:  2019-03-29

Review 3.  Prospective and therapeutic screening value of non-coding RNA as biomarkers in cardiovascular disease.

Authors:  Albert Busch; Suzanne M Eken; Lars Maegdefessel
Journal:  Ann Transl Med       Date:  2016-06

4.  Bone Marrow-Derived MicroRNA-223 Works as an Endocrine Genetic Signal in Vascular Endothelial Cells and Participates in Vascular Injury From Kawasaki Disease.

Authors:  Maoping Chu; Rongzhou Wu; Shanshan Qin; Wenfeng Hua; Zhen Shan; Xing Rong; Jingjing Zeng; Lanlan Hong; Yeying Sun; Ying Liu; Wen Li; Shenming Wang; Chunxiang Zhang
Journal:  J Am Heart Assoc       Date:  2017-02-14       Impact factor: 5.501

Review 5.  Kawasaki disease: pathophysiology and insights from mouse models.

Authors:  Magali Noval Rivas; Moshe Arditi
Journal:  Nat Rev Rheumatol       Date:  2020-05-26       Impact factor: 20.543

Review 6.  Epigenetics in Kawasaki Disease.

Authors:  Kaushal Sharma; Pandiarajan Vignesh; Priyanka Srivastava; Jyoti Sharma; Himanshi Chaudhary; Sanjib Mondal; Anupriya Kaur; Harvinder Kaur; Surjit Singh
Journal:  Front Pediatr       Date:  2021-06-25       Impact factor: 3.418

7.  Identification of differentially expressed microRNAs in acute Kawasaki disease.

Authors:  Ye Chen; Yue-Yue Ding; Yan Ren; Lei Cao; Qiu-Qin Xu; Ling Sun; Ming-Guo Xu; Hai-Tao Lv
Journal:  Mol Med Rep       Date:  2017-11-08       Impact factor: 2.952

8.  miR‑186, a serum microRNA, induces endothelial cell apoptosis by targeting SMAD6 in Kawasaki disease.

Authors:  Rongzhou Wu; Danping Shen; Hareshwaree Sohun; Donghui Ge; Xianda Chen; Xuliang Wang; Ruiyao Chen; Yuqing Wu; Jingjing Zeng; Xing Rong; Xiaoping Su; Maoping Chu
Journal:  Int J Mol Med       Date:  2018-01-18       Impact factor: 4.101

9.  Next generation sequencing identifies miRNA-based biomarker panel for lupus nephritis.

Authors:  Yu-Jih Su; I-Chun Lin; Lin Wang; Cheng-Hsien Lu; Yi-Ling Huang; Ho-Chang Kuo
Journal:  Oncotarget       Date:  2018-06-15

10.  MicroRNA-197-3p mediates damage to human coronary artery endothelial cells via targeting TIMP3 in Kawasaki disease.

Authors:  Chaowu Liu; Deguang Yang; Hong Wang; Shengwei Hu; Xiaofei Xie; Li Zhang; Hongling Jia; Qi Qi
Journal:  Mol Cell Biochem       Date:  2021-08-05       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.